Diagnostics manufacturers and even medical device innovators can play roles, says an expert working to raise awareness.
News & Features
Pulmonx released positive one-year-results from the LIBERATE pivotal trial of the Zephyr Endobronchial Valve, which shows the study met all primary and secondary endpoints.
An industry expert discusses how emerging artificial intelligence technologies might shape the healthcare landscape.
If the Amplatzer Amulet Left Atrial Appendage (LAA) occlusion device gains approval in the U.S., the device could go head-to-head with Boston Scientific’s Watchman.
Freenome has initiated a clinical study to help bring an AI-Genomics blood test for colorectal cancer to the U.S. market.
Grail raises $300 million in Series C round to give massive boost to the development of its liquid biopsy applications for cancer.
Where is the evolution of LSR use—for molders, formulators, and especially designers and device engineers—headed in the coming years?
Beta Bionics receives IDE approval from FDA to begin a clinical trial testing the iLet Bionic Pancreas System.
TAVR pioneer Edwards Lifesciences has released positive 30-day data of its Sapien 3 valve at EuroPCR.
Blue Earth Diagnostics’ LOCATE clinical study shows 59% of patients with suspected recurrent prostate cancer had a change in their management plan following an 18F fluciclovine PET/CT scan.